Precision Radiation Oncology (PRO)

Precision Radiation Oncology, also known as the Blue Journal, presents an open access forum of collaboration and exchange for comprehensive and cutting-edge information on basic, translational, and clinical research in radiation oncology. Precision Radiation Oncology is the first English Journal focusing on radiation oncology in China. It is officially endorsed by Chinese Society for Therapeutic Radiology and Oncology (CSTRO), Chinese Radiation Therapy Oncology Group (CRTOG), and the Radiation Oncology Physicians Brance of Chinese Medical Doctor Association. Precision Radiation Oncology (PRO, which is also called BLUE JOURNAL) aims to offer a forum for collaboration and exchange of comprehensive and cutting-edge information on basic, translational, and clinical research in radiation oncology. The editors encourage contributions relevant to radiodiagnosis, radiotherapy, radiation physics, radiation biology, interventional therapy, and nuclear medicine in cancer, including basic cancer research, as well as translational and clinical cancer research. Precision Radiation Oncology is supported by Sino-American Network for Therapeutic Radiology and Oncology(SANTRO), and Chinese Anti-Cancer Association(CA-CA) . Precision Radiation Oncology is an open access journal. Manuscripts accepted for publication will be published as open access articles, immediately free to read, download and share. Authors or their funder will be not required to pay an article publication charge at present.

Precision Radiation Oncology (PRO) is :-

• International, Peer-Reviewed, Open Access, Refereed, Precision Radiation Oncology benefits radiation oncologists, dosimetrists, radiation physicists, radiation biologists, radiation therapists, interventional radiologist, radiologists , Print , Quarterly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2398-7324, Established: 2017, Impact Factor: 2.1
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE